Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Human Induced Pluripotent Stem Cells and the Modelling of Alzheimer’s Disease: The Human Brain Outside the Dish
Godwin Tong, Pablo Izquierdo, Rana Arham Raashid
The Open Neurology Journal (2017) Vol. 11, Iss. 1, pp. 27-38
Open Access | Times Cited: 19

Showing 19 citing articles:

Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models
Sarah Logan, Thiago Arzua, Scott G. Canfield, et al.
Comprehensive physiology (2019), pp. 565-611
Open Access | Times Cited: 106
Microfluidic Brain-on-a-Chip: Perspectives for Mimicking Neural System Disorders
Mirza Ali Mofazzal Jahromi, Amir Abdoli, Mohammad Rahmanian, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 12, pp. 8489-8512
Open Access | Times Cited: 99
Molecular Pharmacology of Rosmarinic and Salvianolic Acids: Potential Seeds for Alzheimer’s and Vascular Dementia Drugs
Solomon Habtemariam
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 458-458
Open Access | Times Cited: 89
Representing Diversity in the Dish: Using Patient-Derived in Vitro Models to Recreate the Heterogeneity of Neurological Disease
Layla T. Ghaffari, Alexander Starr, Andrew T. Nelson, et al.
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 32
Recent advances of induced pluripotent stem cells application in neurodegenerative diseases
Nashwa Amin, Xiaoning Tan, Qiannan Ren, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 95, pp. 109674-109674
Closed Access | Times Cited: 31
Emerging Human Pluripotent Stem Cell-Based Human–Animal Brain Chimeras for Advancing Disease Modeling and Cell Therapy for Neurological Disorders
Yanru Ji, Jenna Lillie McLean, Ranjie Xu
Neuroscience Bulletin (2024) Vol. 40, Iss. 9, pp. 1315-1332
Closed Access | Times Cited: 3
Hyaluronan regulates synapse formation and function in developing neural networks
Emily S. Wilson, Warren Knudson, Karen Litwa
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 27
Using induced pluripotent stem cells for modeling Parkinson’s disease
Minjing Ke, Cheong‐Meng Chong, Huanxing Su
World Journal of Stem Cells (2019) Vol. 11, Iss. 9, pp. 634-649
Open Access | Times Cited: 26
Modeling Progressive Fibrosis with Pluripotent Stem Cells Identifies an Anti-fibrotic Small Molecule
Preethi Vijayaraj, Aspram Minasyan, Abdo Durra, et al.
Cell Reports (2019) Vol. 29, Iss. 11, pp. 3488-3505.e9
Open Access | Times Cited: 22
Pueraria lobata and Daidzein Reduce Cytotoxicity by Enhancing Ubiquitin-Proteasome System Function in SCA3-iPSC-Derived Neurons
I‐Cheng Chen, Kuo‐Hsuan Chang, Yijing Chen, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-18
Open Access | Times Cited: 16
Important advances in Alzheimer’s disease from the use of induced pluripotent stem cells
Fernanda Majolo, Daniel Rodrigo Marinowic, Denise Cantarelli Machado, et al.
Journal of Biomedical Science (2019) Vol. 26, Iss. 1
Open Access | Times Cited: 11
Stem cells technology: a powerful tool behind new brain treatments
Lucienne Nneoma Duru, Zhenzhen Quan, Talal Jamil Qazi, et al.
Drug Delivery and Translational Research (2018) Vol. 8, Iss. 5, pp. 1564-1591
Closed Access | Times Cited: 5
Stem Cell Therapy for Hashimoto's Disease - a Promising Treatment Method?
Oliwia Kozyra, Katarzyna Paluch, Zofia Szypuła, et al.
Quality in Sport (2024) Vol. 21, pp. 53856-53856
Open Access
Evolution of the Research Literature and the Scientific Community of Alzheimer’s Disease from 1983-2017: A 35-Year Survey
Christian P. Robert, Concepción S. Wilson, Richard B. Lipton, et al.
Journal of Alzheimer s Disease (2020) Vol. 75, Iss. 4, pp. 1105-1134
Closed Access | Times Cited: 3
On the utilization of the induced pluripotent stem cell (iPSC) model to study substance use disorders: A scoping review protocol
Wasiri Niemis, Shenita R. Peterson, Chrisabella Javier, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0292238-e0292238
Open Access | Times Cited: 1
Computational Approaches for Supporting Combination Therapy in the Post-Aducanumab Era in Alzheimer’s Disease
Hugo Geerts, Piet van der Graaf
Journal of Alzheimer s Disease Reports (2021) Vol. 5, Iss. 1, pp. 815-826
Open Access | Times Cited: 1
Advances in Alzheimer’s Disease Research: Human Cerebral Organoids
Isabel Liste
American Journal of Biomedical Science & Research (2023) Vol. 18, Iss. 1, pp. 1-5
Open Access
Promising Prospects for Human Cerebral Organoids to Advance Alzheimer's Disease Research
Victoria López-Alonso, Andreea Rosca, Isabel Liste, et al.
Progress in Neurobiology (2023), pp. 1-15
Open Access
Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models
Sarah Logan, Thiago Arzua, Scott G. Canfield, et al.
Comprehensive physiology (2019) Vol. 9, Iss. 2, pp. 565-611
Closed Access
Page 1

Scroll to top